Skip to main content
Home
  • Study projects
  • About us
    • About us
    • Team
    • Our approach
  • FAQ
Sign up
  • Contact
  • Facilities
  • English
  • Français
  • Log in

You are here

  1. Home
  2. Study Projects
  3. Sleep: Insomnia

Sleep: Insomnia

Research into possible treatments for individuals who have difficulty falling or staying asleep

Register
Slaap

Information

Open for enrollment
Condition
The medical condition or disease being investigated in the study.
Insomnia
Reimbursement
Financial reimbursement provided to participants for their time and travel costs.
Yes
Age:
The minimum and maximum age required to be eligible for participation.
18-75y
Placebo
An inactive substance used as a comparator in the study. Some participants may receive a placebo instead of the investigational treatment.
Yes
Sign up today and contribute
Share this studie
  • Share on Facebook
  • Share on Instagram
  • Share on X
  • Share on LinkedIn
  • Copy linkCopied!
Mensen
Safe and reliable participation

✓ Always under medical supervision
✓ Maximum focus on your data privacy (GDPR)
✓ Over +7,500 participants have gone before you

About this study

Insomnia disorder is a chronic sleep-wake disorder characterised by persistent difficulties with sleep initiation, sleep maintenance, or early morning awakening, resulting in significant impairment of daytime functioning and quality of life. This study investigates a potential pharmacological treatment for adults presenting with clinically significant insomnia disorder.

Clinical manifestations of insomnia disorder include:

  • Prolonged sleep onset latency upon bedtime
  • Frequent nocturnal awakenings with difficulty returning to sleep
  • Excessive daytime fatigue and cognitive impairment, including reduced concentration and attention
  • Mood disturbances and increased irritability

Insomnia disorder is frequently associated with:

  • Impaired occupational performance and productivity
  • Deterioration of social functioning and interpersonal relationships
  • Reduced capacity for activities of daily living
  • Elevated risk of psychiatric and somatic comorbidities
Eligibility criteria
  • Men and women aged 18 years or older
  • Difficulties initiating and maintaining sleep
  • Insufficient response to prior therapeutic interventions
How to participate
  1. Register via the online form; you will receive a confirmation e-mail
  2. Our team will contact you for further follow-up and to assess whether participation is clinically appropriate
  3. Begin participation under medical supervision, including a treatment period and follow-up visits

You will receive personalised guidance from our team of physicians and researchers throughout the study. You are encouraged to ask questions at any stage and will receive support at every step to ensure you feel informed and clinically well-supported.

Why your participation matters

By participating, you contribute to the clinical understanding of how adults diagnosed with insomnia disorder respond to a potential therapeutic intervention. The data collected will support the further development of this treatment and may generate valuable evidence for future clinical care.

Andere open studies

Skin conditions

Illustratie ANIMA Research
18-70y

Depression

Illustratie ANIMA Research
18-99y

Sleep Disorders

Slaap
18-65y

Cardiovascular

Illustratie ANIMA Research
18-95y

Rheumatism

Illustratie ANIMA Research
18-65y

Obesity

Obesitas
18-95y

Vaccine: Flu & COVID

Griep
60y+
HomeBuilding the medicine of tomorrow together
  • Study projects
  • About us
  • FAQ

Address

Alkerstraat 28-30-30A-32z
3570 Alken
Belgium

Wetenschapspark 11-13
3590 Diepenbeek

Belgium

Contact

info.arc@animaresearch.com
Onthaal: +32 11 94 91 15

Blijf op de hoogte

  • Facebook
  • LinkedIn
  • Instagram
  • Copyright
  • Disclaimer
  • Privacy policy
  • Manage cookie preferences